PA
Perceptive Advisors Portfolio holdings
AUM
$2.67B
This Quarter Return
+35.59%
1 Year Return
+73.17%
3 Year Return
+837.18%
5 Year Return
+928.4%
10 Year Return
+11,818.46%
AUM
$9.28B
AUM Growth
+$9.28B
(+37%)
Cap. Flow
+$1.17B
Cap. Flow
% of AUM
12.62%
Top 10 Holdings %
Top 10 Hldgs %
43.31%
Holding
162
New
36
Increased
23
Reduced
15
Closed
21
Top Buys
| 1 |
NVTA
Invitae Corporation
NVTA
|
$305M |
| 2 |
HZNP
Horizon Therapeutics Public Limited Company Ordinary Shares
HZNP
|
$226M |
| 3 |
Atea Pharmaceuticals
AVIR
|
$130M |
| 4 |
C4 Therapeutics
CCCC
|
$105M |
| 5 |
KRON
Kronos Bio
KRON
|
$83M |
Top Sells
| 1 |
MYOK
MyoKardia, Inc. Common Stock
MYOK
|
$190M |
| 2 |
CRISPR Therapeutics
CRSP
|
$112M |
| 3 |
IMMU
Immunomedics Inc
IMMU
|
$77.6M |
| 4 |
BPMC
Blueprint Medicines
BPMC
|
$61.6M |
| 5 |
Cogent Biosciences
COGT
|
$53.5M |
Sector Composition
| 1 | Healthcare | 85.79% |
| 2 | Industrials | 0.29% |
| 3 | Materials | 0.22% |
| 4 | Financials | 0.13% |
| 5 | Consumer Discretionary | 0.02% |
